MedWatch

Lundbeck drug linked to fatal cardiac arrest

An extensive study of Danish patient who have died from cardiac arrest casts a shadow on one of the Danish pharmaceutical company Lundbeck’s blockbuster drugs.

Foto: Colourbox

A recent Danish study of people who have died from cardiac arrest implicates Lundbeck’s antidepressant Cipramil. The drug is based on the active substance citalopram, and the study concludes that the number of people who suffer cardiac arrests in the street, at work or in their homes is significantly higher amongst users of medicine based on this substance, than among users of other types of antidepressants.

“There is an unmistakably higher risk of cardiac arrest among users of citalopram. We believe it to be a danger signal, seeing as citalopram is a frequently prescribed drug in this country. But whether or not to discontinue treatment in some cases, would have to be decided in consultation with psychiatrists,” the originator of the study, ph. D. student Peter Weeke from Kardiologisk Overafdeling P at Gentofte Hospital, tells Videnskab.dk.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier